| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2020 | Dawes Karen A63 | Director | Sell | 1,600 | $137.78 | $220,448.01 | -0.2% | |
| May 15, 2020 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 435 | $140.69 | $61,200.15 | -1.6% | |
| May 15, 2020 | Snodgres Jon59 | Chief Financial Officer | Sell | 660 | $140.43 | $92,683.80 | -2.0% | |
| May 13, 2020 | Snodgres Jon59 | Chief Financial Officer | Sale+OE | 15,394 | $128.74 | $1,981,874.77 | -6.4% | |
| May 13, 2020 | Kuriyel Ralf72 | Senior VP, R&D | Sale+OE | 8,000 | $127.80 | $1,022,372.67 | -8.5% | |
| Apr 22, 2020 | Barthelemy Nicolas67 | Director | Sale+OE | 2,688 | $109.99 | $295,653.12 | -47.0% | |
| Apr 20, 2020 | Dawes Karen A63 | Director | Sale+OE | 12,200 | $104.57 | $1,275,717.12 | -5.1% | |
| Apr 3, 2020 | Barthelemy Nicolas67 | Director | Sale+OE | 2,688 | $99.99 | $268,773.12 | -39.8% | |
| Mar 24, 2020 | Cox John | Director | Sell | 1,858 | $96.72 | $179,705.76 | -66.8% | |
| Mar 18, 2020 | Cox John | Director | Sale+OE | 26,736 | $95.27 | $2,547,035.16 | -69.8% |